Biostar

Suprema further enhances cyber security with new BioStar 2 release

Thursday, May 14, 2020 - 7:00am

SEOUL, KOREA, May 14, 2020 - (ACN Newswire) - Suprema, a global leader in security and biometrics, has released a new version BioStar 2 platform, enhancing the cyber security features.

Key Points: 
  • SEOUL, KOREA, May 14, 2020 - (ACN Newswire) - Suprema, a global leader in security and biometrics, has released a new version BioStar 2 platform, enhancing the cyber security features.
  • Suprema BioStar 2 is a web-based, open, and integrated security platform that provides comprehensive functionality for access control and time & attendance.
  • With this enhancement in BioStar 2 v2.8, this upscaled security will be made available not as an option but a default feature of the system.
  • Introducing this new update, Young S. Moon, CEO of Suprema Inc., remarked, "We place absolute top priority to strengthen security measures and reinforce our security framework.

Biostar Technology International, LLC "exonerated from FDA warning letter" says CTO

Wednesday, November 14, 2018 - 3:01am

SANTA CLARITA, Calif., Nov. 13, 2018 /PRNewswire/ -- Biostar Technology International, LLC 4/17/17 (update)

Key Points: 
  • SANTA CLARITA, Calif., Nov. 13, 2018 /PRNewswire/ -- Biostar Technology International, LLC 4/17/17 (update)
    Last year, in 2017, the FDA published a warning letter against Biostar Technology International, LLC in which wrongly accused the company of marketing natural supplements as cancer drugs.
  • The FDA warning letter outlined that natural substances, can't be identified and sold as cancer curing without FDA approval.
  • Biostar Organix Healthcare Association shared a copy of the letter from the FDA dated 08/27/18 , which now is correctly addressed to Biostar Organix Healthcare Association, and no longer Biostar Technology International, LLC.
  • In response to the letter, Ulysses Sheretov, President and CTO of Biostar Technology, LLC said, "Biostar Technology International, LLC unequivocally denies that they owned or operated any of the websites listed in the past FDA warning letter.